POLE2 and renal cell carcinoma: Moreover, Zhang et al. reported that high expression of POLE2 was associated with a poor prognosis of renal cell carcinoma (RCC), with knockdown of POLE2 dramatically inhibiting the proliferation and migration of RCC cells [25].